Accelerating mAb Process Development In The Growing Therapeutics Market

The demand for monoclonal antibodies (mAbs) and their variants, like bispecific antibodies and antibody-drug conjugates, is surging. This webinar dives into the critical areas of mAb process development: stable CHO cell line creation, optimized media and feed selection, and rapid downstream process development using resin high-throughput screening.

Kim Prohaska, Samantha Kupco, and Manuel Matos from Thermo Fisher Scientific share their expertise in early-stage mAb development. They discuss the importance of CHO host cell selection, explore strategies to optimize media and feed for maximum cell growth and productivity, and introduce innovative resin high-throughput screening techniques for streamlined purification.

Key Takeaways:

• Strategies for developing stable CHO cell lines for mAb production
• Tailoring media and feed to meet the specific nutritional needs of your clone
• Leveraging high-throughput screening to accelerate downstream process development and purification

Watch this webinar to learn how to optimize your mAb development process from start to finish.